Developer | Country | Clinical Trial Phase | Strategy |
CanSino Biological Inc./Beijing Institute of Biotechnology | China | I and II | Non-replicating viral vector |
Beijing Institute of Biological Products/ Wuhan Institute of Biological Products | China | I | Inactivated virus |
Sinovac | China | I | Inactivated virus |
University of Oxford | UK | I | Non-Replicating Viral Vector |
BioNTech/Fosun Pharma/Pfizer | USA | I | RNA |
Moderna/NIAID | USA | I | RNA |
Inovio Pharmaceutical | USA | I | DNA |